Loading...

Steven Kayser, PharmD

TitleProfessor Emeritus
SchoolUCSF School of Pharmacy
DepartmentClinical Pharmacy
Address533 Parnassus Avenue
San Francisco CA 94117
Phone415-476-4540
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San FranciscoPharm.D.1970 Pharmacy

    Collapse Overview 
    Collapse overview
    Dr. Steven Kayser is Professor of Clinical Pharmacy and Associate Dean for Global Affairs in the School of Pharmacy at the University of California at San Francisco. He cares for patients on the Cardiology Service and in the Intensive Cardiac Care Unit. Dr. Kayser teaches in the clinical therapeutics curriculum and precepts students in the clinical practice clerkships in cardiology and critical care. He sees patients in the Ambulatory Care Anticoagulation Clinic. He has served in numerous capacities in the Department of Clinical Pharmacy and was a Visiting Professor at Tokyo University of Pharmacy and Life Science in 1995-96. He is a contributing author to numerous textbooks as well as professional publications. Dr. Kayser is a Fellow of the California Society of Health-Systems Pharmacists and an active member of professional associations including the Society of Critical Care Medicine, American Association of Colleges of Pharmacy and the American Society of Health-Systems Pharmacists.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Selected Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Alldredge BK, Kayser SR. In reply. JAMA Intern Med. 2013 Aug 12; 173(15):1473. PMID: 24151653.
      View in: PubMed
    2. Alldredge BK, Kayser SR. Bending the curve toward increased use of generic drugs. JAMA Intern Med. 2013 Feb 11; 173(3):233-4. PMID: 23303368.
      View in: PubMed
    3. Johnson SG, Kayser SR, Attridge RL, Duvall L, Kiser TH, Moote R, Reed BN, Rodgers JE, Erstad B. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update. Pharmacotherapy. 2012 Jun; 32(6):e134-69. PMID: 22467427.
      View in: PubMed
    4. Shin J, Kayser SR. Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort. Pharmacotherapy. 2011 Sep; 31(9):863-70. PMID: 21923587.
      View in: PubMed
    5. Cheng CM, McCurdy MR, Wong HA, Kayser SR. Pros and cons of dabigatran. Am J Health Syst Pharm. 2011 Aug 15; 68(16):1495. PMID: 21817080.
      View in: PubMed
    6. Meeker E, Dennehy CE, Weber EJ, Kayser SR. Emergency department management of patients on warfarin therapy. Ann Emerg Med. 2011 Aug; 58(2):192-9. PMID: 21481971.
      View in: PubMed
    7. Kadafour M, Haugh R, Posin M, Kayser SR, Shin J. Survey on warfarin pharmacogenetic testing among anticoagulation providers. Pharmacogenomics. 2009 Nov; 10(11):1853-60. PMID: 19891559.
      View in: PubMed
    8. Shin J, Kayser SR, Langaee TY. Pharmacogenetics: from discovery to patient care. Am J Health Syst Pharm. 2009 Apr 1; 66(7):625-37. PMID: 19299369.
      View in: PubMed
    9. Cheng CM, Meyer-Massetti C, Kayser SR. A review of three stand-alone topical thrombins for surgical hemostasis. Clin Ther. 2009 Jan; 31(1):32-41. PMID: 19243705.
      View in: PubMed
    10. Kayser SR. The use of nesiritide in the management of acute decompensated heart failure. 2002. Prog Cardiovasc Nurs. 2007; 22(4):89-95. PMID: 18172951.
      View in: PubMed
    11. Kayser SR. Pharmacogenomics and the potential for personalized therapeutics in cardiovascular disease. Prog Cardiovasc Nurs. 2007; 22(2):104-7. PMID: 17541322.
      View in: PubMed
    12. Kayser SR. Dronedarone: in quest of the ideal antiarrhythmic drug. Prog Cardiovasc Nurs. 2007; 22(4):221-4. PMID: 18059201.
      View in: PubMed
    13. Boettger R, Lee J, Rifkin C, Kayser SR. Heart transplantation and altered drug response, Part II: pharmacologic management of post-transplantation complications. Prog Cardiovasc Nurs. 2006; 21(4):219-22. PMID: 17170599.
      View in: PubMed
    14. Boettger R, Lee J, Rifkin C, Kayser S. Heart transplantation and altered drug response, part I: heart transplantation and innervation. Prog Cardiovasc Nurs. 2006; 21(2):100-3. PMID: 16760694.
      View in: PubMed
    15. Dang MT, Hambleton J, Kayser SR. The influence of ethnicity on warfarin dosage requirement. Ann Pharmacother. 2005 Jun; 39(6):1008-12. PMID: 15855242.
      View in: PubMed
    16. Kayser SR. Combination drug therapy in the management of pulmonary arterial hypertension. Prog Cardiovasc Nurs. 2005; 20(4):177-82. PMID: 16276142.
      View in: PubMed
    17. Kayser SR. Practical challenges in the management of oral anticoagulation. Prog Cardiovasc Nurs. 2005; 20(2):80-5. PMID: 15886552.
      View in: PubMed
    18. Voirol P, Kayser SR, Chang CY, Chang QL, Youmans SL. Impact of pharmacists' interventions on the pediatric discharge medication process. Ann Pharmacother. 2004 Oct; 38(10):1597-602. PMID: 15328395.
      View in: PubMed
    19. Lee KW, Kayser SR, Hongo RH, Tseng ZH, Scheinman MM. Famotidine and long QT syndrome. Am J Cardiol. 2004 May 15; 93(10):1325-7. PMID: 15135720.
      View in: PubMed
    20. Kayser SR. Dilemmas in drug therapy. Prog Cardiovasc Nurs. 2003; 18(2):108-11. PMID: 12732804.
      View in: PubMed
    21. Ho R, Kayser SR. Thrombocytopenia associated with antithrombotic therapy in acute coronary syndrome. Prog Cardiovasc Nurs. 2003; 18(4):198-200. PMID: 14605523.
      View in: PubMed
    22. McCart GM, Kayser SR. Therapeutic equivalency of low-molecular-weight heparins. Ann Pharmacother. 2002 Jun; 36(6):1042-57. PMID: 12022908.
      View in: PubMed
    23. Kayser SR. The use of nesiritide in the management of acute decompensated heart failure. Prog Cardiovasc Nurs. 2002; 17(2):89-95. PMID: 11986542.
      View in: PubMed
    24. Glatter K, Yang Y, Chatterjee K, Modin G, Cheng J, Kayser S, Scheinman MM. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Circulation. 2001 Jan 16; 103(2):253-7. PMID: 11208685.
      View in: PubMed
    25. Kato Y, Fujii T, Mizoguchi N, Takata N, Ueda K, Feldman MD, Kayser SR. Potential interaction between ritonavir and carbamazepine. Pharmacotherapy. 2000 Jul; 20(7):851-4. PMID: 10907977.
      View in: PubMed
    26. Kayser SR. Spironolactone in the management of congestive heart failure. Prog Cardiovasc Nurs. 2000; 15(4):145-8. PMID: 11098527.
      View in: PubMed
    27. Kayser SR. Low-molecular-weight heparins in the management of cardiovascular conditions. Prog Cardiovasc Nurs. 1998; 13(1):34-40. PMID: 9614687.
      View in: PubMed
    28. Kayser SR. Use of epoprostenol (Flolan) in the management of primary pulmonary hypertension. Prog Cardiovasc Nurs. 1998; 13(3):39-41, 45. PMID: 9950022.
      View in: PubMed
    29. Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med. 1997 Jun 15; 126(12):959-62. PMID: 9182473.
      View in: PubMed
    30. Banerji S, Kayser SR. Antiarrhythmic drug therapy--Part IV: Ventricular arrhythmias. Prog Cardiovasc Nurs. 1997; 12(3):32-6. PMID: 9287365.
      View in: PubMed
    31. Kayser SR. Clinical trials update. Prog Cardiovasc Nurs. 1997; 12(2):30-3, 44. PMID: 9195645.
      View in: PubMed
    32. Kayser SR. Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter. Prog Cardiovasc Nurs. 1997; 12(1):39-43. PMID: 9058463.
      View in: PubMed
    33. Kayser SR. Dilemmas in drug therapy. Prog Cardiovasc Nurs. 1997; 12(4):29-31, 33. PMID: 9433731.
      View in: PubMed
    34. Mao L, El-Naggar AK, Fan YH, Lee JS, Lippman SM, Kayser S, Lotan R, Hong WK. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res. 1996 Dec 15; 56(24):5600-4. PMID: 8971162.
      View in: PubMed
    35. Kayser SR. Antiarrhythmic drug therapy--Part II: Specific drugs. Prog Cardiovasc Nurs. 1996; 11(3):33-8. PMID: 8878298.
      View in: PubMed
    36. Kayser SR. Antiarrhythmic drug therapy--part III: atrial fibrillation. Prog Cardiovasc Nurs. 1996; 11(4):35-43,45. PMID: 8969004.
      View in: PubMed
    37. Kayser SR. Antiarrhythmic drug therapy--Part I: General principles of drug selection. Prog Cardiovasc Nurs. 1996; 11(2):33-7. PMID: 8718961.
      View in: PubMed
    38. Kayser SR. Management of venous thromboembolic (VTE) disease--Part II: Treatment. Prog Cardiovasc Nurs. 1996; 11(1):36-40, 46. PMID: 8657708.
      View in: PubMed
    39. Kayser SR. Management of venous thromboembolic (VTE) disease--Part I: Prevention. Prog Cardiovasc Nurs. 1995; 10(4):31-6. PMID: 8584548.
      View in: PubMed
    40. Kayser SR. Calcium channel blockers--is vasoselectivity relevant? Prog Cardiovasc Nurs. 1995; 10(1):35-9. PMID: 7770440.
      View in: PubMed
    41. Trujillo T, Kayser SR. Alcohol and cardiovascular disease. Prog Cardiovasc Nurs. 1995; 10(2):36-9, 46. PMID: 7651949.
      View in: PubMed
    42. Kayser SR. Pharmacologic management of cardiac arrest: an update perspective. Prog Cardiovasc Nurs. 1995; 10(3):35-41. PMID: 7479661.
      View in: PubMed
    43. Kayser SR. New drugs 1994: trapidil, torsemide. Prog Cardiovasc Nurs. 1994; 9(3):38-40. PMID: 7971937.
      View in: PubMed
    44. Quan DJ, Kayser SR. Ketorolac induced acute renal failure following a single dose. J Toxicol Clin Toxicol. 1994; 32(3):305-9. PMID: 8007038.
      View in: PubMed
    45. Kayser SR. Management of chronic congestive heart failure. Part II--Selection of treatment. Prog Cardiovasc Nurs. 1994; 9(2):30-7. PMID: 7937687.
      View in: PubMed
    46. Kayser SR. Management of chronic congestive heart failure: Part I--General introduction to treatment. Prog Cardiovasc Nurs. 1994; 9(1):39-42. PMID: 8058693.
      View in: PubMed
    47. Kayser SR, Trujillo T. The role of magnesium in cardiovascular disease. Prog Cardiovasc Nurs. 1994; 9(4):37-40. PMID: 7846002.
      View in: PubMed
    48. Kayser SR. Drug interaction with coumarin anticoagulants. Prog Cardiovasc Nurs. 1993; 8(1):40-5. PMID: 8372087.
      View in: PubMed
    49. Callaham M, Barton CW, Kayser S. Potential complications of high-dose epinephrine therapy in patients resuscitated from cardiac arrest. JAMA. 1991 Mar 6; 265(9):1117-22. PMID: 1995996.
      View in: PubMed
    50. De Marco T, Daly PA, Liu M, Kayser S, Parmley WW, Chatterjee K. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol. 1987 May; 9(5):1131-8. PMID: 3033043.
      View in: PubMed
    51. Davis LJ, Kayser SR, Hubsher J, Williams RL. Effect of oxaprozin on the steady-state anticoagulant activity of warfarin. Clin Pharm. 1984 May-Jun; 3(3):295-7. PMID: 6734092.
      View in: PubMed
    52. Watanabe AS, McCart G, Shimomura S, Kayser S. Systematic approach to drug information requests. Am J Hosp Pharm. 1975 Dec; 32(12):1282-5. PMID: 1211401.
      View in: PubMed
    Steven's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP